Skip Navigation

CEO Kevin MacDonald in Forbes: How AI Can Help Prevent Opioid Theft

Blog

CEO Kevin MacDonald in Forbes: How AI Can Help Prevent Opioid Theft

As a member of the Forbes Technology Council, Kevin MacDonald recently penned an article on…

Blog

The Data Science Behind Drug Diversion Detection with Bluesight for Controlled Substances

Data science has emerged as an ally for hospital directors of pharmacy in the continuous …

Blog

50 Hospitals Adopt Bluesight for Controlled Substances to Reconcile Discrepancies Faster, Implement 100% Audit and Close the Diversion Gap

Kit Check introduced Bluesight for Controlled Substances (BCS) in 2017 at ASHP Midyear. At the …

Blog

Video: How to Close the Diversion Gap

Kevin MacDonald, co-founder and CEO of Kit Check, at the Heath Connect Partners fall conference…

Blog

ZDNet Video Interview: How machine learning and AI can help detect opioid theft

The misuse and addiction of opioids has sparked a crisis across the United States, including …

Blog

Kit Check Closes the Diversion Gap with Launch of Bluesight IRIS and Reveals Which Hospital Employees Exhibit Behaviors Consistent with Controlled Substance Theft

Leading Automated Medication Solutions Provider for Hospital Pharmacies Leverages Machine Learning to Enhance Diversion Identification …

Blog

Three Trends in Diversion Prevention, Detection, and Response from IHFDA

Two weeks ago I had the pleasure of attending the International Health Facility Diversion Association…

2 of 2